Transaction in Own Shares

AI SummaryClose X

RTW Biotech Opportunities Ltd repurchased 329,580 ordinary shares on 13 November 2026 at $2.45 per share and will hold them in treasury; issued share capital is 345,967,440 with 28,173,792 shares held in treasury (no voting rights), leaving total voting rights of 317,793,648. The buyback was made under shareholder authority permitting repurchases up to 14.99% (authority valid until the next AGM, expected 2027). No maximum consideration was set, but the company will not pay a price that equates to a premium to net asset value and intends to retain repurchased shares in treasury.

Disclaimer*

UK 100

Latest directors dealings